30 results
Clues to Differential Diagnosis of Central Cyanosis: Onset of cyanosis, Clubbing, Secondary erythrocytosis, Auscultation, X-ray, Echocardiography,
Clues to Differential ... heart defect - Pulmonary ... diseases - Pulmonary ... Central #Cardiology #Causes ... #Table #Comparison
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... class (30-day all cause ... Hemodynamics (Stable ... @nickmmark #Pulmonary ... stratification #criticalcare
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... with caution in pulmonary ... Treat underlying cause ... Treat underlying cause ... #Stable #NarrowComplex
Hordeolum vs Chalazion

Hordeolum (Stye):
 • Location: Most commonly found at or near an eyelash follicle
 •
eyelash follicle • Cause ... , swelling • Treatment ... upper lid • Cause ... Stye #Chalazion #Comparison ... #Table
Shock Classification Types - Pathophysiology Comparison

Obstructive Shock:
 • Obstructive shock is characterized by a blockage in
Pathophysiology Comparison ... in blood flow caused ... Pulmonary embolism ... infarction. end-stage ... #criticalcare #
Shock - Differential Diagnosis by Classification

Hypovolemic (Intravascular volume depletion)
 - Hemorrhagic 
   • Trauma
exacerbation (any cause ... flow) - Massive pulmonary ... Classification #Table ... #CriticalCare
Stage I - Redistribution
In a normal chest film with the patient standing erect, the pulmonary vessels
Stage I - Redistribution ... standing erect, the pulmonary ... The pulmonary vascular ... non-perfused vessels and causes ... In these cases comparison
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison ... Table Some patients ... medication assisted treatment ... Hospital Opioid Use Treatment ... Buprenorphine #Comparison
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
without other cause ... : 33% • Treatment ... , and CXR with pulmonary ... hematology #diagnosis #comparison ... #table
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Blood Pressure, Pulmonary ... Resistance, Main Uses ... Vasopressors #Properties #Table ... Effect #Management #Comparison